Quanterix Releases Financial Results for the Second Quarter of 2026 August 10, 2026 Quanterix Releases Financial Results for the Second Quarter of 2026
Quanterix Names Jim Gute Chief Commercial Officer August 10, 2026 Quanterix Names Jim Gute Chief Commercial Officer
Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12 August 6, 2026 Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026 August 4, 2026 Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages July 14, 2026 Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 16, 2026 Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer June 9, 2026 Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer